NM_001278293.3:c.281T>C
Variant summary
Our verdict is Pathogenic. The variant received 13 ACMG points: 13P and 0B. PM1PP2PP3_ModeratePP5_Very_Strong
The NM_001278293.3(ARL6):c.281T>C(p.Ile94Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000018 in 1,612,688 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_001278293.3 missense
Scores
Clinical Significance
Conservation
Publications
- Bardet-Biedl syndrome 3Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp, G2P
- retinitis pigmentosa 55Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- retinitis pigmentosaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Bardet-Biedl syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 13 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.0000197  AC: 3AN: 152054Hom.:  0  Cov.: 32 show subpopulations 
GnomAD2 exomes  AF:  0.0000319  AC: 8AN: 251138 AF XY:  0.0000295   show subpopulations 
GnomAD4 exome  AF:  0.0000178  AC: 26AN: 1460634Hom.:  0  Cov.: 30 AF XY:  0.0000248  AC XY: 18AN XY: 726686 show subpopulations 
Age Distribution
GnomAD4 genome  0.0000197  AC: 3AN: 152054Hom.:  0  Cov.: 32 AF XY:  0.0000135  AC XY: 1AN XY: 74262 show subpopulations 
ClinVar
Submissions by phenotype
Bardet-Biedl syndrome 3;C3150808:Retinitis pigmentosa 55    Pathogenic:1 
This sequence change replaces isoleucine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 94 of the ARL6 protein (p.Ile94Thr). This variant is present in population databases (rs771054395, gnomAD 0.01%). This missense change has been observed in individuals with ARL6-related conditions (PMID: 23219996, 28041643, 33946315). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 438186). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. For these reasons, this variant has been classified as Pathogenic. -
Bardet-Biedl syndrome 3;C2936862:Bardet-Biedl syndrome 1;C3150808:Retinitis pigmentosa 55    Pathogenic:1 
- -
ARL6-related disorder    Pathogenic:1 
The ARL6 c.281T>C variant is predicted to result in the amino acid substitution p.Ile94Thr. This variant has been reported in the homozygous state in a patient with Bardet-Biedl syndrome (see, for example, Khan et al. 2013. PubMed ID: 23219996). This variant is reported in 0.013% of alleles in individuals of South Asian descent in gnomAD. This variant is interpreted as likely pathogenic. -
Retinitis pigmentosa    Pathogenic:1 
- -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at